Related Experiment Video
Updated: May 30, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[(R)evolution in pediatric diabetology]
1Clinique de Diabétologie, Hôpital Universitaire des Enfants Reine Fabiola, ULB, Bruxelles. hdorchy@ulb.ac.be
Insights
Modern diabetes management allows children with diabetes to thrive, achieving normal physical and intellectual development. Optimal glycemic control and expert multidisciplinary care are key to preventing long-term complications.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Diseases
Background:
- The discovery of insulin revolutionized type 1 diabetes treatment, transforming a fatal childhood illness into a manageable condition.
- Significant advancements in diabetes care have led to improved quality of life for young patients, though treatment strategies continue to evolve.
Observation:
- Young individuals with diabetes can achieve comparable physical and intellectual competitiveness to their non-diabetic peers through proper self-management and near-normal glycemic control.
- Effective management of chronic hyperglycemia is crucial for preventing debilitating long-term complications such as blindness, renal failure, amputations, and cardiovascular disease.
Findings:
- Multidisciplinary teams with pediatric diabetologists and sufficient caseloads are essential for optimal care and expertise in managing childhood diabetes.
- International comparisons indicate that twice-daily free-mix insulin regimens may lead to significantly lower HbA1c levels in children and adolescents compared to other insulin delivery methods.
- Ongoing research explores preventative strategies for type 1 diabetes, including vitamin D supplementation and dietary interventions like avoiding beta-casein.
Implications:
- Optimizing pediatric diabetes care requires continuous comparison of quality of care and patient well-being across different treatment teams, avoiding dogmatic approaches.
- Further research into effective insulin regimens and preventative measures is crucial for improving long-term outcomes in type 1 diabetes.
- While a definitive cure for type 1 diabetes remains elusive, current management strategies significantly enhance patient health and longevity.
Abstract:
Before the discovery of insulin 87 years ago, all diabetic children died within a few weeks or months following diagnosis. Since then, improvements in the treatment and live of young diabetics have sometimes occurred in (r)evolutions that have caused debate among physicians. They are briefly reviewed in this paper. Today's young diabetics, properly trained in self-monitoring and self-treatment, are as competitive physically and intellectually as their non-diabetic peers provided their glycemic control (i.e., their glycated hemoglobin levels) is kept close to normal. They escape the potentially incapacitating complications associated with chronic hyperglycemia of several decades' duration: blindness, renal failure, amputations, excess cardiovascular mortality, etc. To achieve this favourable outcome, diabetic children should be followed by multidisciplinary teams that include pediatric diabetologists and have a large enough case load to acquire a high level of expertise. Quality of care and patient well-being should be compared across teams with the goal of optimizing both these parameters. Any dogmatism must be avoided. The international comparisons of the Hvidøre Study Group on Childhood Diabetes have shown that diabetic children and adolescents on twice-daily free-mix regimens have significantly lower HbA1c than those on basal-bolus, pumps or twice-daily premixed/insulin regimens. Attempts to prevent type 1 diabetes are under way: vitamin D supplementation, avoidance of beta-casein (cow's milk hypothesis), etc. A definitive cure for type 1 diabetes mellitus is difficult to foresee.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Ketoacidosis ll: Pathophysiology
Type I Diabetes I: Introduction
Type II Diabetes II: Pathophysiology

